Linked Life Data

7574786

Source:http://linkedlifedata.com/resource/pubmed/id/7574786

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1995-11-9
pubmed:abstractText
Thirteen patients with invasive bladder cancer treated by induction intra-arterial chemotherapy in combination with radiotherapy achieved a complete response (CR). All of them were treated by prophylactic intra-arterial chemotherapy using pirarubicin (10), epirubicin (2) and carboplatin (1). The treatment was given once a month for 2 years. In the followup period from 14 to 43 months (median; 22.5 months), only one of the 13 patients had an invasive recurrence of bladder cancer and died of it. Ten of the 13 patients are now disease-free and alive with functional bladder. The complications of this therapy were mild and tolerable. The results suggest that prophylactic intra-arterial chemotherapy is a useful regimen for CR patients with invasive bladder cancer after induction therapy.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0385-0684
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1657-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
[Prophylactic intra-arterial chemotherapy for CR patients with invasive bladder cancer after induction therapy].
pubmed:affiliation
Dept. of Urology, National Shikoku Cancer Center Hospital.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract